444 related articles for article (PubMed ID: 30938892)
1. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus.
Li Y; Wang C; Wang J; Zhou Y; Ye F; Zhang Y; Cheng X; Huang Z; Liu K; Fei G; Zhong C; Zeng M; Jin L
Mov Disord; 2019 Jun; 34(6):884-892. PubMed ID: 30938892
[TBL] [Abstract][Full Text] [Related]
2. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
[TBL] [Abstract][Full Text] [Related]
3. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N
Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859
[TBL] [Abstract][Full Text] [Related]
4. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
Liu Q; Wang P; Liu C; Xue F; Wang Q; Chen Y; Hou R; Chen T
BMC Neurol; 2023 Aug; 23(1):301. PubMed ID: 37580712
[TBL] [Abstract][Full Text] [Related]
5. MRI index of glymphatic system mediates the influence of locus coeruleus on cognition in Parkinson's disease.
Wang X; Huang P; Haacke EM; Wu P; Zhang X; Zhang H; Cheng Z; Tang R; Liu F; Liu Y; Shi X; Liu P; Zhang Y; Jin Z; Chen S; He N; Yan F
Parkinsonism Relat Disord; 2024 Jun; 123():106558. PubMed ID: 38518543
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the noradrenergic system in Parkinson's disease: an 11C-MeNER PET and neuromelanin MRI study.
Sommerauer M; Fedorova TD; Hansen AK; Knudsen K; Otto M; Jeppesen J; Frederiksen Y; Blicher JU; Geday J; Nahimi A; Damholdt MF; Brooks DJ; Borghammer P
Brain; 2018 Feb; 141(2):496-504. PubMed ID: 29272343
[TBL] [Abstract][Full Text] [Related]
7. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study.
Knudsen K; Fedorova TD; Hansen AK; Sommerauer M; Otto M; Svendsen KB; Nahimi A; Stokholm MG; Pavese N; Beier CP; Brooks DJ; Borghammer P
Lancet Neurol; 2018 Jul; 17(7):618-628. PubMed ID: 29866443
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
[TBL] [Abstract][Full Text] [Related]
9. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
[TBL] [Abstract][Full Text] [Related]
10. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Role of Locus Coeruleus Degeneration in Essential Tremor and Parkinson's Disease with Sleep Disorders.
Liu S; Zhou C; Fang Y; Zhu B; Wu H; Wu C; Guo T; Wu J; Wen J; Qin J; Chen J; Duanmu X; Tan S; Guan X; Xu X; Zhang M; Zhang B; Zhao G; Yan Y
J Parkinsons Dis; 2024; 14(4):833-842. PubMed ID: 38728202
[TBL] [Abstract][Full Text] [Related]
12. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
[TBL] [Abstract][Full Text] [Related]
13. Neuromelanin-Sensitive Magnetic Resonance Imaging Changes in the Locus Coeruleus/Subcoeruleus Complex in Patients with Typical and Atypical Parkinsonism.
Nobileau A; Gaurav R; Chougar L; Faucher A; Valabrègue R; Mangone G; Leu-Semenescu S; Lejeune FX; Corvol JC; Arnulf I; Vidailhet M; Grabli D; Degos B; Lehéricy S
Mov Disord; 2023 Mar; 38(3):479-484. PubMed ID: 36592065
[TBL] [Abstract][Full Text] [Related]
14. Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson's disease.
O'Callaghan C; Hezemans FH; Ye R; Rua C; Jones PS; Murley AG; Holland N; Regenthal R; Tsvetanov KA; Wolpe N; Barker RA; Williams-Gray CH; Robbins TW; Passamonti L; Rowe JB
Brain; 2021 Sep; 144(8):2513-2526. PubMed ID: 33783470
[TBL] [Abstract][Full Text] [Related]
15. Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
Laurencin C; Lancelot S; Brosse S; Mérida I; Redouté J; Greusard E; Lamberet L; Liotier V; Le Bars D; Costes N; Thobois S; Boulinguez P; Ballanger B
Brain; 2024 Apr; 147(4):1377-1388. PubMed ID: 37787503
[TBL] [Abstract][Full Text] [Related]
16. The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease.
García-Lorenzo D; Longo-Dos Santos C; Ewenczyk C; Leu-Semenescu S; Gallea C; Quattrocchi G; Pita Lobo P; Poupon C; Benali H; Arnulf I; Vidailhet M; Lehericy S
Brain; 2013 Jul; 136(Pt 7):2120-9. PubMed ID: 23801736
[TBL] [Abstract][Full Text] [Related]
17. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
18. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
[TBL] [Abstract][Full Text] [Related]
19. Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study.
Pellecchia MT; Picillo M; Santangelo G; Longo K; Moccia M; Erro R; Amboni M; Vitale C; Vicidomini C; Salvatore M; Barone P; Pappatà S
Acta Neurol Scand; 2015 May; 131(5):275-81. PubMed ID: 25644029
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
